Search - tctmd.com

Displaying 81 - 100 of 451

Sort: Relevancy | Date

Presentation NY Valves 2024

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Presenter: Ole De Backer

June 05, 2024

News Conference News ESOC 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

Todd Neale

May 17, 2024

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Conference News

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Yael L. Maxwell

May 06, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Conference News ACC 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

L.A. McKeown

April 07, 2024

News Conference News ACC 2024

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Yael L. Maxwell

April 05, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Todd Neale

March 15, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Conference News PCR London Valves 2023

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Shelley Wood

November 20, 2023

Advertisement

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Debate Continues on TAVI Choice for Women With Small Annuli

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Evoque and Patisiran: A Tale of Two Regulatory Journeys

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Debating the Role of T-TEER in the Sickest Patients

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

TAVI, SAVR Almost Equally Performed in California Patients Under 60

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content